The Calgary Brain Bank

With the financial assistance from two donors, we have established a neurodegenerative disease brain bank at the University of Calgary. At autopsy, tissues from anatomically specific regions are frozen in liquid nitrogen vapour and stored in small, bar-coded cryovials. Cases include patients with de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of neurological sciences 2018-05, Vol.45 (S1), p.S5-S5
Hauptverfasser: Joseph, J.T., Stys, P., Braun, J.E.A., Alvarezveronesi, A., Smith, E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S5
container_issue S1
container_start_page S5
container_title Canadian journal of neurological sciences
container_volume 45
creator Joseph, J.T.
Stys, P.
Braun, J.E.A.
Alvarezveronesi, A.
Smith, E.
description With the financial assistance from two donors, we have established a neurodegenerative disease brain bank at the University of Calgary. At autopsy, tissues from anatomically specific regions are frozen in liquid nitrogen vapour and stored in small, bar-coded cryovials. Cases include patients with dementia, movement disorders, demyelinating diseases, and normal controls. We prepare additional FFPE blocks for diagnosis or banking. Sampling includes all major areas of cortex and most subcortical structures. All brains, including “normal” controls, are characterized with a basic set of stains and major classification schemata are used for Alzheimer and Lewy body diseases. These tissues are available to investigators with IRB-approved research on human tissues Control tissue is important in the study of age-associated neurodegeneration. We preserve tissues from areas of brain that either are severely or minimally affected by neurodegeneration (e.g. in Alzheimer disease, Brodmann areas 9 and 17, respectively). In our “normal” aging cohort, which includes patients with no described neurodegenerative diseases, we find frequent evidence of low-stage Alzheimer or Lewy body related pathological changes. We also find relatively frequent small vessel disease, which in part relates to our preferential selection of patient’s who died suddenly. In preliminary studies, we have examined amyloid plaque structure with confocal microscopy using beta-sheet sensitive dyes and have studied the distribution of different chaperones in normal brain.
doi_str_mv 10.1017/cjn.2018.49
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2799848228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_cjn_2018_49</cupid><sourcerecordid>2799848228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1399-dd198bf76a49d2d168130b7199536cf3da748098ba6a02f5ec9615ea04f18f93</originalsourceid><addsrcrecordid>eNptjztPwzAURi0EEqEwITFHYkQJ9zp-jjQqD6kSS3bLSeyS0CbFpgP_nkStxMJ0l6Pz3UPILUKOgPKx6YecAqqc6TOSUOAyA-T8nCRQoMxQSLwkVzH2AFRwwRJyV324tLTbjQ0_6TLYbkiXdvi8JhfebqO7Od0FqZ5XVfmard9f3sqnddZgoXXWtqhV7aWwTLe0RaGwgFqi1rwQjS9aK5mCCbHCAvXcNVogdxaYR-V1sSD3R-0-jF8HF79NPx7CMC0aKrVWTFGqJurhSDVhjDE4b_ah200PGwQzd5up28zdhs3O7ETbXR26duP-pP_xv6xmVoE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2799848228</pqid></control><display><type>article</type><title>The Calgary Brain Bank</title><source>Cambridge University Press Journals Complete</source><creator>Joseph, J.T. ; Stys, P. ; Braun, J.E.A. ; Alvarezveronesi, A. ; Smith, E.</creator><creatorcontrib>Joseph, J.T. ; Stys, P. ; Braun, J.E.A. ; Alvarezveronesi, A. ; Smith, E.</creatorcontrib><description>With the financial assistance from two donors, we have established a neurodegenerative disease brain bank at the University of Calgary. At autopsy, tissues from anatomically specific regions are frozen in liquid nitrogen vapour and stored in small, bar-coded cryovials. Cases include patients with dementia, movement disorders, demyelinating diseases, and normal controls. We prepare additional FFPE blocks for diagnosis or banking. Sampling includes all major areas of cortex and most subcortical structures. All brains, including “normal” controls, are characterized with a basic set of stains and major classification schemata are used for Alzheimer and Lewy body diseases. These tissues are available to investigators with IRB-approved research on human tissues Control tissue is important in the study of age-associated neurodegeneration. We preserve tissues from areas of brain that either are severely or minimally affected by neurodegeneration (e.g. in Alzheimer disease, Brodmann areas 9 and 17, respectively). In our “normal” aging cohort, which includes patients with no described neurodegenerative diseases, we find frequent evidence of low-stage Alzheimer or Lewy body related pathological changes. We also find relatively frequent small vessel disease, which in part relates to our preferential selection of patient’s who died suddenly. In preliminary studies, we have examined amyloid plaque structure with confocal microscopy using beta-sheet sensitive dyes and have studied the distribution of different chaperones in normal brain.</description><identifier>ISSN: 0317-1671</identifier><identifier>EISSN: 2057-0155</identifier><identifier>DOI: 10.1017/cjn.2018.49</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Abstracts ; Alzheimer's disease ; Brain ; Neurodegeneration</subject><ispartof>Canadian journal of neurological sciences, 2018-05, Vol.45 (S1), p.S5-S5</ispartof><rights>Copyright © The Canadian Journal of Neurological Sciences Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0317167118000495/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,776,780,27903,27904,55606</link.rule.ids></links><search><creatorcontrib>Joseph, J.T.</creatorcontrib><creatorcontrib>Stys, P.</creatorcontrib><creatorcontrib>Braun, J.E.A.</creatorcontrib><creatorcontrib>Alvarezveronesi, A.</creatorcontrib><creatorcontrib>Smith, E.</creatorcontrib><title>The Calgary Brain Bank</title><title>Canadian journal of neurological sciences</title><addtitle>Can. J. Neurol. Sci</addtitle><description>With the financial assistance from two donors, we have established a neurodegenerative disease brain bank at the University of Calgary. At autopsy, tissues from anatomically specific regions are frozen in liquid nitrogen vapour and stored in small, bar-coded cryovials. Cases include patients with dementia, movement disorders, demyelinating diseases, and normal controls. We prepare additional FFPE blocks for diagnosis or banking. Sampling includes all major areas of cortex and most subcortical structures. All brains, including “normal” controls, are characterized with a basic set of stains and major classification schemata are used for Alzheimer and Lewy body diseases. These tissues are available to investigators with IRB-approved research on human tissues Control tissue is important in the study of age-associated neurodegeneration. We preserve tissues from areas of brain that either are severely or minimally affected by neurodegeneration (e.g. in Alzheimer disease, Brodmann areas 9 and 17, respectively). In our “normal” aging cohort, which includes patients with no described neurodegenerative diseases, we find frequent evidence of low-stage Alzheimer or Lewy body related pathological changes. We also find relatively frequent small vessel disease, which in part relates to our preferential selection of patient’s who died suddenly. In preliminary studies, we have examined amyloid plaque structure with confocal microscopy using beta-sheet sensitive dyes and have studied the distribution of different chaperones in normal brain.</description><subject>Abstracts</subject><subject>Alzheimer's disease</subject><subject>Brain</subject><subject>Neurodegeneration</subject><issn>0317-1671</issn><issn>2057-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptjztPwzAURi0EEqEwITFHYkQJ9zp-jjQqD6kSS3bLSeyS0CbFpgP_nkStxMJ0l6Pz3UPILUKOgPKx6YecAqqc6TOSUOAyA-T8nCRQoMxQSLwkVzH2AFRwwRJyV324tLTbjQ0_6TLYbkiXdvi8JhfebqO7Od0FqZ5XVfmard9f3sqnddZgoXXWtqhV7aWwTLe0RaGwgFqi1rwQjS9aK5mCCbHCAvXcNVogdxaYR-V1sSD3R-0-jF8HF79NPx7CMC0aKrVWTFGqJurhSDVhjDE4b_ah200PGwQzd5up28zdhs3O7ETbXR26duP-pP_xv6xmVoE</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Joseph, J.T.</creator><creator>Stys, P.</creator><creator>Braun, J.E.A.</creator><creator>Alvarezveronesi, A.</creator><creator>Smith, E.</creator><general>Cambridge University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>201805</creationdate><title>The Calgary Brain Bank</title><author>Joseph, J.T. ; Stys, P. ; Braun, J.E.A. ; Alvarezveronesi, A. ; Smith, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1399-dd198bf76a49d2d168130b7199536cf3da748098ba6a02f5ec9615ea04f18f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abstracts</topic><topic>Alzheimer's disease</topic><topic>Brain</topic><topic>Neurodegeneration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joseph, J.T.</creatorcontrib><creatorcontrib>Stys, P.</creatorcontrib><creatorcontrib>Braun, J.E.A.</creatorcontrib><creatorcontrib>Alvarezveronesi, A.</creatorcontrib><creatorcontrib>Smith, E.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Psychology</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Canadian journal of neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joseph, J.T.</au><au>Stys, P.</au><au>Braun, J.E.A.</au><au>Alvarezveronesi, A.</au><au>Smith, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Calgary Brain Bank</atitle><jtitle>Canadian journal of neurological sciences</jtitle><addtitle>Can. J. Neurol. Sci</addtitle><date>2018-05</date><risdate>2018</risdate><volume>45</volume><issue>S1</issue><spage>S5</spage><epage>S5</epage><pages>S5-S5</pages><issn>0317-1671</issn><eissn>2057-0155</eissn><abstract>With the financial assistance from two donors, we have established a neurodegenerative disease brain bank at the University of Calgary. At autopsy, tissues from anatomically specific regions are frozen in liquid nitrogen vapour and stored in small, bar-coded cryovials. Cases include patients with dementia, movement disorders, demyelinating diseases, and normal controls. We prepare additional FFPE blocks for diagnosis or banking. Sampling includes all major areas of cortex and most subcortical structures. All brains, including “normal” controls, are characterized with a basic set of stains and major classification schemata are used for Alzheimer and Lewy body diseases. These tissues are available to investigators with IRB-approved research on human tissues Control tissue is important in the study of age-associated neurodegeneration. We preserve tissues from areas of brain that either are severely or minimally affected by neurodegeneration (e.g. in Alzheimer disease, Brodmann areas 9 and 17, respectively). In our “normal” aging cohort, which includes patients with no described neurodegenerative diseases, we find frequent evidence of low-stage Alzheimer or Lewy body related pathological changes. We also find relatively frequent small vessel disease, which in part relates to our preferential selection of patient’s who died suddenly. In preliminary studies, we have examined amyloid plaque structure with confocal microscopy using beta-sheet sensitive dyes and have studied the distribution of different chaperones in normal brain.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><doi>10.1017/cjn.2018.49</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0317-1671
ispartof Canadian journal of neurological sciences, 2018-05, Vol.45 (S1), p.S5-S5
issn 0317-1671
2057-0155
language eng
recordid cdi_proquest_journals_2799848228
source Cambridge University Press Journals Complete
subjects Abstracts
Alzheimer's disease
Brain
Neurodegeneration
title The Calgary Brain Bank
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A31%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Calgary%20Brain%20Bank&rft.jtitle=Canadian%20journal%20of%20neurological%20sciences&rft.au=Joseph,%20J.T.&rft.date=2018-05&rft.volume=45&rft.issue=S1&rft.spage=S5&rft.epage=S5&rft.pages=S5-S5&rft.issn=0317-1671&rft.eissn=2057-0155&rft_id=info:doi/10.1017/cjn.2018.49&rft_dat=%3Cproquest_cross%3E2799848228%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2799848228&rft_id=info:pmid/&rft_cupid=10_1017_cjn_2018_49&rfr_iscdi=true